View in EDS

abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile

Saved in:
Bibliographic Details
Title: abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile
Authors: Kereiakes, Dean J.1 lindner@fuse.net, Lincoff, A.Michael2, Anderson, Keaven M.3, Achenbach, Robert3, Patel, Kamlesh3, Barnathan, Elliot3, Califf, Robert M.4, Topol, Eric J.2, EPIC Investigators (CORPORATE AUTHOR), EPILOG investigators (CORPORATE AUTHOR), EPISTENT investigators (CORPORATE AUTHOR)
Source: American Journal of Cardiology. Sep2002, Vol. 90 Issue 6, p628-630. 3p.
Database: Academic Search Ultimate
Description
ISSN:00029149
DOI:10.1016/S0002-9149(02)02568-7